| 000 | 01810 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517054146.0 | ||
| 264 | 0 | _c20160801 | |
| 008 | 201608s 0 0 eng d | ||
| 022 | _a1873-4251 | ||
| 024 | 7 |
_a10.2174/1570162x13666150929112135 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCalcagno, Andrea | |
| 245 | 0 | 0 |
_aRaltegravir Plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-Positive Patients: Safety, Efficacy and Pharmacokinetics. _h[electronic resource] |
| 260 |
_bCurrent HIV research _c2016 |
||
| 300 |
_a54-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadverse effects |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aDrug Resistance, Multiple, Viral _xdrug effects |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV Integrase Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMaintenance Chemotherapy _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNevirapine _xadverse effects |
| 650 | 0 | 4 |
_aRaltegravir Potassium _xadverse effects |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aViral Load |
| 700 | 1 | _aMontrucchio, Chiara | |
| 700 | 1 | _aCapetti, Amedeo | |
| 700 | 1 | _aGuaraldi, G | |
| 700 | 1 | _aCenderello, G | |
| 700 | 1 | _aCalza, Leonardo | |
| 700 | 1 | _aLanzafame, M | |
| 700 | 1 | _aMarinaro, Letizia | |
| 700 | 1 | _aTettoni, M C | |
| 700 | 1 | _aTrentini, Laura | |
| 700 | 1 | _aD'Avolio, Aantonio | |
| 700 | 1 | _aDi Perri, Giovanni | |
| 700 | 1 | _aBonora, Stefano | |
| 773 | 0 |
_tCurrent HIV research _gvol. 14 _gno. 1 _gp. 54-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1570162x13666150929112135 _zAvailable from publisher's website |
| 999 |
_c25304764 _d25304764 |
||